The American Optometric Association Health Policy Institute has released a new brief to educate the public on blepharitis, its symptoms and treatment options. “The AOA’s Health Policy ...

An expert provides insights into the cost of misdiagnosed Demodex blepharitis and payer considerations for a potential cost-effective treatment. Eric D. Donnenfeld, MD; underscores the ...

The company's strategic moves appear to be setting the stage for sustained progress in the treatment of Demodex blepharitis. While analysts project continued sales growth, detailed financial ...